Sigma Healthcare Limited (ASX:SIG)
Australia
· Delayed Price · Currency is AUD | Market Cap | 4.50B |
| Revenue (ttm) | 3.48B |
| Net Income (ttm) | -3.00M |
| Shares Out | 1.57B |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | 71.79 |
| Dividend | 0.01 (0.35%) |
| Ex-Dividend Date | Oct 1, 2024 |
| Volume | 33,866,179 |
| Average Volume | 12,165,806 |
| Open | 3.050 |
| Previous Close | 3.090 |
| Day's Range | 2.960 - 3.070 |
| 52-Week Range | 1.065 - 3.320 |
| Beta | 0.18 |
| RSI | 48.59 |
| Earnings Date | Mar 20, 2025 |
About Sigma Healthcare
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; and third and fourth-party logistics services to pharmaceutical manufacturers and other s... [Read more]
Financial Performance
In 2023, Sigma Healthcare's revenue was 3.32 billion, a decrease of -9.24% compared to the previous year's 3.66 billion. Earnings were 4.51 million, an increase of 148.98%.
Financial StatementsNews
Ex-intern becomes billionaire in Australia pharmacy merger
Mario Verrocchi, who rose from intern to become Chemist Warehouse CEO, is now worth at least $2.5 billion after a merger with Australia's Sigma Healthcare.
Chemist Warehouse shareholders seal $30b merger in 16-minute meeting
Chemist Warehouse has cleared one of the final hurdles for its ASX listing after Sigma Healthcare shareholders backed a proposal to merge the companies.
Chemist Warehouse sales top $5b in six months ahead of ASX listing
The privately held pharmacy giant’s shareholders will vote on a merger with Sigma Healthcare on Wednesday, a deal which would create a $29 billion company.
Chemist Warehouse franchisees mull sell-down post $30b merger; banks circle
Chemist Warehouse’s $30 billion merger with Sigma Healthcare could unleash nearly $1 billion of sell-downs as some large franchisees weigh selling their stakes.
Sigma Rallies to 17-Year High on Chemist Warehouse Deal Approval
Sigma Healthcare Ltd. shares surged to their highest since 2007 after Australia’s competition regulator approved the company’s A$8.8 billion ($5.8 billion) merger with pharmacy chain Chemist Warehouse...
Pharmacy lobby says Chemist Warehouse concessions are ‘tokenistic’
The influential industry group is urging the competition regulator to reject an $8.8 billion merger with Sigma Healthcare. A decision is due early next month.
Sigma Healthcare Ltd (SIGGF) (Q2 2025) Earnings Call Transcript Highlights: Strong Revenue ...
Sigma Healthcare Ltd (SIGGF) (Q2 2025) Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Expansion
Half Year 2025 Sigma Healthcare Ltd Earnings Call Transcript
Half Year 2025 Sigma Healthcare Ltd Earnings Call Transcript
Competition regulator delays $8.8b Chemist Warehouse deal approval
The ACCC is undertaking more analysis of the transaction, which would merge the pharmacy giant into Sigma Healthcare. A decision won’t be made until October.